The Trump administration’s Monday executive order could restructure how Americans buy prescription drugs, pushing them away from insurers and pharmacy-benefit managers and toward cash pay options. A White House official said on a press call early Monday that a new executive order from President Donald Trump will push drugmakers to sell prescription drugs at low prices directly to patients. Investors had been dreading the threatened order that Trump on Sunday night called “one of the most consequential Executive Orders in our Country’s history.”

Continue Reading

View Comments